Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Ruth Pritchett, Danai Bem, Grace Turner, et al.
Thrombosis and Haemostasis (2019) Vol. 119, Iss. 02, pp. 294-307
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 01, pp. 020-047
Open Access | Times Cited: 370
Pathophysiology of atrial fibrillation and chronic kidney disease
Wern Yew Ding, Dhiraj Gupta, Christopher F. Wong, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 4, pp. 1046-1059
Open Access | Times Cited: 86
Atrial Fibrillation in Older People: Concepts and Controversies
Zafraan Zathar, Anne Karunatilleke, Ameenathul M. Fawzy, et al.
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 77
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
Journal of Arrhythmia (2021) Vol. 37, Iss. 6, pp. 1389-1426
Open Access | Times Cited: 68
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update
Ben Freedman, Gerhard Hindricks, Amitava Banerjee, et al.
Global Heart (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 62
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
Diana A. Gorog, Ying X. Gue, Tze‐Fan Chao, et al.
EP Europace (2022) Vol. 24, Iss. 11, pp. 1844-1871
Open Access | Times Cited: 34
Atrial Fibrillation and Stroke
Hani Essa, Andrew Hill, Gregory Y.H. Lip
Cardiac Electrophysiology Clinics (2021) Vol. 13, Iss. 1, pp. 243-255
Closed Access | Times Cited: 37
Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial
Kate Williams, Rakesh Narendra Modi, Andrew Dymond, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e065066-e065066
Open Access | Times Cited: 22
Female Sex as a Risk Modifier for Stroke Risk in Atrial Fibrillation: Using CHA2DS2-VASc versus CHA2DS2-VA for Stroke Risk Stratification in Atrial Fibrillation: A Note of Caution
Peter Brønnum Nielsen, Thure Filskov Overvad
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 06, pp. 894-898
Closed Access | Times Cited: 37
Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
J Farinha, Ian Jones, Gregory Y.H. Lip
European Heart Journal Supplements (2022) Vol. 24, Iss. Supplement_A, pp. A42-A55
Open Access | Times Cited: 19
Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry
Valentina Bayer, Agnieszka Kotalczyk, Bory Kea, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 6
Open Access | Times Cited: 18
The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis
Belayneh Kefale, Gregory M. Peterson, Corinne Mirkazemi, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2024) Vol. 10, Iss. 6, pp. 488-506
Open Access | Times Cited: 3
Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions
Fatima Ali‐Ahmed, Karen S. Pieper, Rebecca North, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2020) Vol. 6, Iss. 4, pp. 263-272
Open Access | Times Cited: 23
A targeted educational intervention increases oral anticoagulation rates in high-risk atrial fibrillation patients
Roop Dutta, John Ryan, Sally Hurley, et al.
Heart Rhythm O2 (2024) Vol. 5, Iss. 5, pp. 294-300
Open Access | Times Cited: 2
Ischemic stroke subtypes: risk factors, treatments, and 1-month prognosis – The Lille, France Stroke Registry
Léonie Langanay, Roberto Sanchez, Aghilès Hamroun, et al.
Journal of Stroke and Cerebrovascular Diseases (2024) Vol. 33, Iss. 8, pp. 107761-107761
Closed Access | Times Cited: 2
A Systematic Review of Economic Aspects of Service Interventions to Increase Anticoagulation Use in Atrial Fibrillation
Nicholas Jones, William Crawford, Yaling Yang, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 03, pp. 394-405
Closed Access | Times Cited: 13
Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
Liang Hai-feng, Xin Du, Yingchun Zhou, et al.
Medical Science Monitor (2019) Vol. 25, pp. 4691-4698
Open Access | Times Cited: 14
Clinicians’ views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis
Ruth Pritchett, Joanne Clarke, Kate Jolly, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0232484-e0232484
Open Access | Times Cited: 14
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
Monika Kozieł, Michał Mazurek, Christine Teutsch, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1969-1969
Open Access | Times Cited: 14
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
Yutao Guo, Agnieszka Kotalczyk, Jacopo Francesco Imberti, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2021) Vol. 8, Iss. 6, pp. 651-658
Closed Access | Times Cited: 12
Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation
Magdalena Domek, Jakub Gumprecht, Michał Mazurek, et al.
Journal of Cardiovascular Pharmacology (2019) Vol. 74, Iss. 6, pp. 491-498
Open Access | Times Cited: 13
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New Strategies
Marco Proietti, Deirdre A. Lane
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 03, pp. 369-371
Open Access | Times Cited: 12
Understanding the global burden of atrial fibrillation and regional variations: we need improvement
Marco Vitolo, Gregory Y.H. Lip
Cardiovascular Research (2020) Vol. 117, Iss. 6, pp. 1420-1422
Open Access | Times Cited: 12
Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial
Jafna L. Cox, Laura Hamilton, Lehana Thabane, et al.
American Heart Journal (2024) Vol. 273, pp. 102-110
Closed Access | Times Cited: 1
Development and Validation of a Predictive Model for Intracranial Haemorrhage in Patients on Direct Oral Anticoagulants
Yuanyuan Liu, Linjie Li, Jingge Li, et al.
Clinical and Applied Thrombosis/Hemostasis (2024) Vol. 30
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top